维普中文期刊产品整合服务
910篇 您的检索式:作者名="Todorovic"
    题名 作者 年代 出处 被引量
1Primary gastric mucosa associated lymphoid tissue lymphoma: Clinical data predicted treatment outcome显示文摘AIM: To determine clinical characteristics and treatment outcome of gastric lymphoma after chemotherapy and immuno-chemotherapy. METHODS: Thirty four patients with primary gastric mucosa associated lymphoid tissue (MALT) lymphoma (Ann Arbor stages Ⅰ to Ⅳ) were enrolled. All had upper gastric endoscopy, abdominal ultrasonography, CT and H pylori status assessment (histology and serology). After anti-H pylori treatment and initial chemotherapy, patients were re-examined every 4 mo. RESULTS: Histological regression of the lymphoma was complete in 22/34 (64.7%) and partial in 9 (26.5%) patients. Median follow up time for these 31 responders was 60 mo (range 48-120). No regression was noted in 3 patients. Among the 25 (73.5%) H pylori positive patients, the eradication rate was 100%.CONCLUSION: Using univariate analysis, predictive factors for overall survival were international prognostic index (IPI) score, hemoglobin level, erythrocyte sedimentation rate (ESR), and platelet numbers (P < 0.005). In addition to this, Cox proportion hazard model differentiate IPI score, ESR, and platelets as predictors of survival.Milena Todorovic Bela Balint Miodrag Jevtic Nada Suvajdzic Amela Ceric Dragana Stamatovic Olivera Markovic Maja Perunicic Slobodan Marjanovic Miodrag Krstic 2008World Journal of Gastroenterology2008,14,15:10
2制干辣椒F_1代中色素含量的变异和遗传显示文摘研究了2个制干红辣椒F1代中色素含量的变异和遗传。以Gorogled6为试验母本,Negral和Kalocsai801分别为试验父本进行杂交。颜色的变异性在2个F1代表现出加性遗传,但也有一种例外。Gorogled6×Negral的F1代极显著地表明色素含量由加性值决定。第2个F1代即Gorogled6×Kalocsai801仅在1997年表明了与上面第1个F1代相似的结果。在本试验中,F1代色素含量的遗传用d/a比值(1.75~7.96)来表示,并显示出这种性状的超显性遗传。假设和实际的杂种优势作用极显著。Todorova V. Todorov Y. 徐乃林(译) 上官金虎(译) 庄灿然(译) 2006辣椒杂志2006,,2:6
3Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors显示文摘Giulia Mesiano Maja Todorovic Loretta Gammaitoni Valeria Leuci Lidia Giraudo Diego Fabrizio Carnevale-Schianca Franca Fagioli Wanda Piacibello Massimo Aglietta Dario Sangiolo 2012Expert Opinion on Biological Therapy2012,,6:5
4Mesenchymal Stem Cell and Islet Co-Transplantation Promotes Graft Revascularization and Function显示文摘Taihei Ito Shin Itakura Ivan Todorov Jeffrey Rawson Sadaki Asari Jonathan Shintaku Indu Nair Kevin Ferreri Fouad Kandeel Yoko Mullen 2010Transplantation2010,,12:3
5Automatic sources of aggression显示文摘Alexander Todorov John A. Bargh 2001Aggression and Violent Behavior2001,,1:2
6Expression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+strains:An immunohistochemical study显示文摘瞄准:为了与长期的胃炎在成年病人的胃的上皮调查不同 cytokeratins (CK ) 的表示,与 Helicobacter pylori (H pylori ) 感染了 cagA+ 紧张。方法:CK 7 的表示, 8, 18, 19 和 20 在 84 个病人的窦的胃的活体检视组织化学地是学习免疫。所有 CK 是在 cagA+H pylori 胃炎(57 个案例) 染色的免疫, non-H pylori 胃炎(17 个案例) 和正常胃粘膜(10 个案例) 。结果:在 cagA+ H pylori 胃炎, CK8 从表面上皮可比较地被表示到正常的窦粘膜到深腺。CK18 和 CK 19 的分发是未改变的,即表示的 transmucosal,而是紧张在与正常相比的小凹的区域是不同的胃粘膜。Cytokeratin 18 免疫反应在与 H pylori 否定的胃炎和控制相比的 H pylori 积极的胃炎的小凹的上皮是显著地更高的。相反,在 CK19 免疫反应的减少发生在 H pylori 积极的胃炎的小凹的上皮。在没有 H pylori 感染的正常、煽动的窦粘膜, CK20 在表面上皮和上面的小凹的区域强烈 / 中等并且同类地被表示,但是在 H, pylori 导致了胃炎在小凹的区域的表示的重要减少被注意。通常,在正常窦的粘膜和 H pylori 否定的胃炎,, CK7 的表示没被观察在关于半 cagA+ , H 感染 pylori 的病人,节制颈的焦点的 CK7 免疫反应,卷的腺区域被登记,特别在区域与更严重煽动性渗入。结论:在 CK 7 的表示的改变, 18, 19 和 20 在感染 cagA+ 紧张的成年病人和 CK8 的正常表示发生在 H 联系 pylori 的长期的胃炎的窦粘膜。在不同 cytokeratins 表示力量的改变贡献在 H 感染 pylori 的胃粘膜观察的上皮的紧密的连接变弱。Vera Todorovic Neda Drndarevic Olivera Mitrovic Institutefor MedicalResearch Aleksandra Sokic-Milutinovic Tomica Milosavljevic Marjan Micev Ivan Nikolic Thomas Wex Peter Malfertheiner 2006World Journal of Gastroenterology2006,12,12:2
7Beyond 11% Efficiency: Characteristics of State‐of‐the‐Art Cu2ZnSn(S,Se)4 Solar Cells显示文摘Teodor K. Todorov Jiang Tang Santanu Bag Oki Gunawan Tayfun Gokmen Yu Zhu David B. Mitzi 2012Adv. Energy Mater2012,,:2
8Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma显示文摘AIM:To evaluate the clinical characteristics of splenic marginal-zone lymphoma (SMZL) following antigen expression and the influence of therapeutic approaches on clinical outcome and overall survival (OS).METHODS: A total of 30 patients with typical histological and immunohistochemical SMZL patterns were examined. Splenectomy plus chemotherapy was applied in 20 patients, while splenectomy as a single treatment-option was performed in 10 patients. Prognostic factor and overall survival rate were analyzed.RESULTS: Complete remission (CR) was achieved in 20 (66.7%), partial remission (PR) in seven (23.3%), and lethal outcome due to disease progression occurred in three (10.0%) patients. Median survival of patients with a splenectomy was 93.0 mo and for patients with splenectomy plus chemotherapy it was 107.5 mo (Log rank=0.056, P>0.05). Time from onset of first symptoms to the beginning of the treatment (mean 9.4 mo) was influenced by spleen dimensions, as measured by computerized tomography and ultra-sound (t=2.558, P=0.018). Strong positivity (+++) of CD20 antigen expression in splenic tissue had a positive influence on OS (Log rank=5.244, P<0.05). The analysis of factors interfering with survival (by the Kaplan-Meier method) revealed that gender, general symptoms, clinical stage, and spleen infiltration type (nodular vs diffuse) had no significant (P>0.05) effects on the OS. The expression of other antigens (immunohistochemistry) also had no effect on survival-rate, as measured by a χ2 test (P>0.05).CONCLUSION: Initial splenectomy combined with chemotherapy has been shown to be beneficial due to its advanced remission rate/duration; however, a larger controlled clinical study is required to conf irm our findings.Rajko Milosevic Milena Todorovic Bela Balint Miodrag Jevtic Miodrag Krstic Elizabeta Ristanovic Nebojsa Antonijevic Mirjana Pavlovic Maja Perunicic Milan Petrovic Biljana Mihaljevic 2009World Journal of Gastroenterology2009,15,32:2
9CuInS2 films for photovoltaic applications deposited by a low-cost method 显示文摘Todorov T Cordoncillo E Sanchez-Royo J 2006Chem Mater2006,18,13:1
10Pediocin ST18, an anti-listerial bacteriocin produced by Pediococcus pentosaceus STI8 isolated from boza, a traditional cereal beverage from Bulgaria显示文摘Todorov SD Dicks LMT 2005Process Biochem2005,40,1:1
11Epstein-Barvirus hepatitisassociated with icterus-a case report显示文摘Canovic P Gajovic O Todorovic Z 2006Med Pregl2006,59,3:1
12Cychn A andβ- catenin expression in actinic kemtosis, Bowen' s disease and invasive squamous cell carcinoma of the skin显示文摘Brasanac D Boricic I Todorovic V 2005Br J Dermatol2005,153,6:1
13Bacteriocins from Lactobacillus plantarum production, ge- netic organization and mode of action 显示文摘Todorov S D 2009Brazilian Journal of Microbiology2009,40,2:1
14Serotonergic organization of the central nervous system显示文摘Timotijevic I Stankovic Z Todorovic M 2012Psychiatr Danub2012,24,3:1
15Variance risk premium dynamics:the role of jumps显示文摘Todorov V 0,,:1
16Characterization of a 3944 Da bacteriocin, produced by Ente rococcus mundtii ST15, with activity against Gram-positive and Gram-negative bacteria显示文摘De Kwaadsteniet M Todorov SD Knoetze H 2005International Journal of Food Microbiology2005,105,3:1
17Cytokine-induced killer (cik) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors显示文摘Mesiano G Todorovic M Gammaitoni L 2012Expert Opinion on Biological Therapy2012,12,6:1
18Generic existence and uniqueness of solution to linear semi - infinite optimization problems 显示文摘Todorov M 1985Number Funct Anal Optim1985,8,:1
19Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors 显示文摘Mesiano G Todorovic M Gammaitoni L 2012Expert Opin Biol Ther2012,12,6:1
20Mesenchymal stem cell and islet co-transplantation promotes graft revascularization and function显示文摘Ito T ltakura S Todorov I 2010Transplantation2010,89,12:1
返回顶部 每页显示:
共46页 首页 上一页 第1页 下一页 末页 /46 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费